We are live on ! Find out more
AIA

Affinity Investment Advisors Portfolio holdings

AUM $160M
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+8.12%
1 Year Est. Return
+42.7%
3 Year Est. Return
+120.28%
5 Year Est. Return
+162.3%
10 Year Est. Return
+508.38%
AUM
$228M
AUM Growth
+$17.4M
Cap. Flow
+$6.01M
Cap. Flow %
2.64%
Top 10 Hldgs %
25.51%
Holding
168
New
27
Increased
49
Reduced
39
Closed
25

Top Buys

Rank Stock Value
1
BLK icon
Blackrock
BLK
+$3.24M
2
CPB icon
Campbell Soup
CPB
+$2.78M
3
GILD icon
Gilead Sciences
GILD
+$1.74M
4
AKAM icon
Akamai
AKAM
+$1.65M
5
FAF icon
First American
FAF
+$1.55M

Sector Composition

Rank Sector Weight
1 Technology 17.81%
2 Healthcare 16.76%
3 Financials 14.9%
4 Industrials 10.75%
5 Consumer Discretionary 10.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRUP icon
51
Trupanion
TRUP
$1.05B
$1.38M 0.6%
17,430
-3,449
-17% -$207K
MAS icon
52
Masco
MAS
$14.1B
$1.31M 0.57%
+23,719
New +$1.33M
HZNP
53
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.3M 0.57%
16,804
-7,121
-30% -$490K
KHC icon
54
Kraft Heinz
KHC
$31B
$1.24M 0.55%
41,514
-2,199
-5% -$73.2K
INSP icon
55
Inspire Medical Systems
INSP
$1.42B
$1.24M 0.54%
9,608
-1,340
-12% -$148K
TNDM icon
56
Tandem Diabetes Care
TNDM
$1.29B
$1.14M 0.5%
10,078
-3,186
-24% -$335K
AMT icon
57
American Tower
AMT
$79.9B
$1.12M 0.49%
4,640
+1,220
+36% +$309K
RH icon
58
RH
RH
$3.17B
$1.11M 0.49%
2,914
-8
-0.3% -$2.52K
PFSI icon
59
PennyMac Financial
PFSI
$3.92B
$1.09M 0.48%
18,767
PCRX icon
60
Pacira BioSciences
PCRX
$1.03B
$1.02M 0.45%
16,919
-370
-2% -$21.5K
VCYT icon
61
Veracyte
VCYT
$3.52B
$944K 0.41%
29,052
-4,871
-14% -$155K
PGR icon
62
Progressive
PGR
$123B
$943K 0.41%
9,964
COUP
63
DELISTED
Coupa Software Incorporated
COUP
$894K 0.39%
3,259
-808
-20% -$236K
COP icon
64
ConocoPhillips
COP
$144B
$874K 0.38%
26,604
+7,305
+38% +$277K
MDC
65
DELISTED
M.D.C. Holdings, Inc.
MDC
$869K 0.38%
19,929
ENSG icon
66
The Ensign Group
ENSG
$10.2B
$853K 0.37%
14,952
LRCX icon
67
Lam Research
LRCX
$379B
$827K 0.36%
24,930
-3,360
-12% -$116K
NOMD icon
68
Nomad Foods
NOMD
$1.7B
$820K 0.36%
32,190
CMC icon
69
Commercial Metals
CMC
$7.61B
$811K 0.36%
+40,596
New +$844K
EFOR
70
Everforth Inc
EFOR
$1.12B
$781K 0.34%
12,289
-370
-3% -$25.5K
ALLO icon
71
Allogene Therapeutics
ALLO
$659M
$763K 0.33%
+20,242
New +$763K
EGIO
72
DELISTED
Edgio, Inc. Common Stock
EGIO
$762K 0.33%
3,309
-112
-3% -$28K
BCC icon
73
Boise Cascade
BCC
$2.67B
$754K 0.33%
18,900
EVBG
74
DELISTED
Everbridge, Inc. Common Stock
EVBG
$727K 0.32%
5,782
-22
-0.4% -$2.98K
MBUU icon
75
Malibu Boats
MBUU
$538M
$723K 0.32%
14,587
-9
-0.1% -$489

Similar funds

Affinity Investment Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, Affinity Investment Advisors held 168 positions worth $228M, up 8.2% from $210M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Affinity Investment Advisors's Q3 2020 filing shows 27 new, 49 increased, 39 reduced and 25 closed positions. Its largest new stake was Blackrock: 5,670 shares worth $3.19M. The largest sale was Intercontinental Exchange, an estimated $2.64M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Affinity Investment Advisors's largest Q3 2020 buy was Blackrock: 5,670 shares worth $3.19M.
  • Affinity Investment Advisors added most to Gilead Sciences in Q3 2020, an estimated $1.74M increase.
  • Affinity Investment Advisors's biggest Q3 2020 reduction was Intercontinental Exchange, cutting an estimated $2.64M.
  • Affinity Investment Advisors fully exited iShares Core S&P 500 ETF in Q3 2020, selling an estimated $2.62M.
  • Affinity Investment Advisors's ten largest holdings make up 26% of its $228M portfolio in Q3 2020.
  • Affinity Investment Advisors opened 27 new positions and closed 25 in Q3 2020.
  • Affinity Investment Advisors's portfolio value rose 8.2% quarter-over-quarter to $228M.

Based on Affinity Investment Advisors's 13F filing for Q3 2020, filed 13 Nov 2020.